Correlated Motions of Conserved Polar Motifs Lay out a Plausible Mechanism of G Protein-Coupled Receptor Activation.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
30 04 2021
Historique:
received: 23 03 2021
revised: 17 04 2021
accepted: 28 04 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 21 9 2021
Statut: epublish

Résumé

Recent advancements in the field of experimental structural biology have provided high-resolution structures of active and inactive state G protein-coupled receptors (GPCRs), a highly important pharmaceutical target family, but the process of transition between these states is poorly understood. According to the current theory, GPCRs exist in structurally distinct, dynamically interconverting functional states of which populations are shifted upon binding of ligands and intracellular signaling proteins. However, explanation of the activation mechanism, on an entirely structural basis, gets complicated when multiple activation pathways and active receptor states are considered. Our unbiased, atomistic molecular dynamics simulations of the μ opioid receptor (MOP) revealed that transmission of external stimulus to the intracellular surface of the receptor is accompanied by subtle, concerted movements of highly conserved polar amino acid side chains along the 7th transmembrane helix. This may entail the rearrangement of polar species and the shift of macroscopic polarization in the transmembrane domain, triggered by agonist binding. Based on our observations and numerous independent indications, we suggest amending the widely accepted theory that the initiation event of GPCR activation is the shift of macroscopic polarization between the ortho- and allosteric binding pockets and the intracellular G protein-binding interface.

Identifiants

pubmed: 33946214
pii: biom11050670
doi: 10.3390/biom11050670
pmc: PMC8146931
pii:
doi:

Substances chimiques

Ligands 0
OPRM1 protein, human 0
Receptors, Opioid, mu 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Science. 2012 Jul 13;337(6091):232-6
pubmed: 22798613
Br J Pharmacol. 2018 Jul;175(14):2834-2845
pubmed: 28266020
Nature. 2012 Mar 21;485(7398):321-6
pubmed: 22437502
Science. 2000 Aug 4;289(5480):739-45
pubmed: 10926528
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Nature. 2014 Feb 13;506(7487):191-6
pubmed: 24413399
Science. 1973 Dec 28;182(4119):1359-61
pubmed: 4128222
Proteins. 2006 Mar 1;62(4):1053-61
pubmed: 16355416
Biochim Biophys Acta. 2011 Nov;1808(11):2761-71
pubmed: 21819968
FEBS Lett. 1999 Mar 26;447(2-3):318-24
pubmed: 10214970
Angew Chem Int Ed Engl. 2013 Sep 16;52(38):10112-5
pubmed: 23904331
J Biol Chem. 1995 Jul 14;270(28):16683-8
pubmed: 7622478
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
PLoS Comput Biol. 2019 Jan 24;15(1):e1006689
pubmed: 30677023
BMC Cell Biol. 2012 Mar 19;13:6
pubmed: 22429589
J Am Chem Soc. 2014 Oct 15;136(41):14554-9
pubmed: 25229711
Chem Rev. 2017 Jan 11;117(1):139-155
pubmed: 27622975
Neuropharmacology. 2017 May 15;118:46-58
pubmed: 28283391
J Comput Chem. 2009 Dec;30(16):2785-91
pubmed: 19399780
Biochemistry. 2002 Feb 12;41(6):2075-88
pubmed: 11827555
Br J Pharmacol. 2015 Jan;172(2):311-6
pubmed: 24517854
Sci Rep. 2017 Sep 12;7(1):11255
pubmed: 28900175
Trends Pharmacol Sci. 2008 Aug;29(8):421-9
pubmed: 18621424
Nature. 2015 Aug 20;524(7565):315-21
pubmed: 26245379
J Biol Chem. 1994 Jan 28;269(4):2790-5
pubmed: 7507928
Bioinformatics. 2017 Jan 1;33(1):133-134
pubmed: 27578804
Nat Commun. 2019 May 20;10(1):2234
pubmed: 31110175
J Biol Chem. 2000 Jun 9;275(23):17321-7
pubmed: 10748160
Nature. 2015 Aug 20;524(7565):375-8
pubmed: 26245377
Biochem Pharmacol. 2015 Jun 15;95(4):290-300
pubmed: 25896847
Biochem Biophys Res Commun. 2008 Jan 4;365(1):82-8
pubmed: 17980152
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
J Biol Chem. 2002 Sep 27;277(39):36577-84
pubmed: 12145300
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18684-9
pubmed: 22031696
PLoS Comput Biol. 2007 Feb 23;3(2):e34
pubmed: 17319738
Angew Chem Int Ed Engl. 2010 Sep 10;49(38):6778-80
pubmed: 20715028
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Nature. 1997 Apr 3;386(6624):499-502
pubmed: 9087409
Nat Chem Biol. 2011 Sep 19;7(10):657-8
pubmed: 21931312
Adv Biophys. 1985;19:133-65
pubmed: 2424281
Nat Chem Biol. 2005 Jul;1(2):98-103
pubmed: 16408006
Nature. 2018 Jun;558(7711):547-552
pubmed: 29899455
J Biol Chem. 2004 Jul 23;279(30):31268-76
pubmed: 15161928
Nature. 2012 Dec 20;492(7429):387-92
pubmed: 23222541
J Chem Inf Model. 2016 Mar 28;56(3):563-70
pubmed: 26863088
Nat Rev Drug Discov. 2017 Dec;16(12):829-842
pubmed: 29075003
Biochemistry. 2014 Aug 12;53(31):5140-9
pubmed: 25073009
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):23096-23105
pubmed: 32868434
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Nat Methods. 2019 Feb;16(2):151-162
pubmed: 30664776
Structure. 2016 Jun 7;24(6):997-1007
pubmed: 27210286

Auteurs

Argha Mitra (A)

Laboratory of Chemical Biology, Institute of Biochemistry, Biological Research Centre, Szeged, 62. Temesvári krt., H-6726 Szeged, Hungary.

Arijit Sarkar (A)

Laboratory of Chemical Biology, Institute of Biochemistry, Biological Research Centre, Szeged, 62. Temesvári krt., H-6726 Szeged, Hungary.

Márton Richárd Szabó (MR)

Laboratory of Chemical Biology, Institute of Biochemistry, Biological Research Centre, Szeged, 62. Temesvári krt., H-6726 Szeged, Hungary.
Department of Biochemistry, Faculty of Medicine, University of Szeged, 9 Dóm sq., H-6720 Szeged, Hungary.

Attila Borics (A)

Laboratory of Chemical Biology, Institute of Biochemistry, Biological Research Centre, Szeged, 62. Temesvári krt., H-6726 Szeged, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH